As we navigate through the midpoint of the decade, the long-term outlook for the pharmaceutical quality sector has never been more robust. According to current GMP Market Projections, the industry is expected to sustain a compound annual growth rate (CAGR) of approximately 6.8%, potentially reaching a market valuation of over USD 2.64 billion by 2032. This sustained expansion is...

The Spain market research for early 2026 highlights a landscape defined by rapid industrialization and the rise of world-class manufacturing centers. Leading the charge are Spain Market Key Manufacturers such as Viralgen (a Bayer/AskBio subsidiary), which has recently inaugurated its expanded MSAT (Manufacturing, Science and Technology) laboratories to bridge the gap between process development...